A case of simultaneous presence of primary endometrial carcinoma and metastasis of a breast carcinoma to the ovary after 5 years of tamoxifen therapy.
We report a case of a 43-year-old woman with the simultaneous presence of a primary uterine endometrial cancer and metastasis of breast cancer to the ovary after 5 years of tamoxifen therapy. Tamoxifen therapy lengthens recurrence-free survival of the patient. However, the risk of endometrial cancer and the possibility of recurrence of breast cancer also must be considered.
Ishioka
S
S
Department of Obstetrics and Gynecology, Sapporo Medical University, Japan.
Sagae
S
S
Kobayashi
K
K
Sugimura
M
M
Nishioka
Y
Y
Kudo
R
R
D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007633:Keratins / Q000032:analysis; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000556:secondary* / Q000601:surgery; D010052:Ovariectomy; D011960:Receptors, Estrogen / Q000032:analysis; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D013629:Tamoxifen; D007633:Keratins